$28.85
-6.9%HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries. The company's platform provides insights on blood flow, stenosis, and plaque volume and composition by overcoming the limitations of traditional non-invasive imaging tests. The company was founded in 2007 and is headquartered in Mountain View, California.
Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.
Conservative capital structure. The company relies primarily on equity financing, indicating low financial risk.
Strong working capital position provides significant operational flexibility and financial cushion.
Asset-light business model with high liquidity. Majority of assets are easily convertible to cash.
Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.
HTFL • NASDAQ
| Heartflow, Inc. Common Stock Balance Sheet | Dec 2025 | Dec 2024 | Dec 2023 |
|---|---|---|---|
ASSETS | |||
CURRENT ASSETS | |||
44.8M | 51.4M | 122.8M | |
132M | 0.0 | 0.0 | |
176.8M | 51.4M | 122.8M | |
29.3M | 27.1M | 22.5M | |
29.3M | 24.6M | 20.5M | |
0.0 | 2.5M | 2M | |
0.0 | 3M | 2.6M | |
14.1M | 812K | 598K | |
220.2M | 82.3M | 148.4M | |
NON-CURRENT ASSETS | |||
26.1M | 20M | 22.9M | |
0.0 | 7.8M | 7.9M | |
0.0 | 7.8M | 7.9M | |
103.4M | 0.0 | 0.0 | |
9.8M | 8.7M | 5.7M | |
139.2M | 36.4M | 36.6M | |
359.5M | 118.7M | 185.1M | |
LIABILITIES | |||
CURRENT LIABILITIES | |||
3.2M | 2.9M | 2.9M | |
3.2M | 2.9M | 2.9M | |
0.0 | 21.8M | 19.2M | |
5.9M | 5.4M | 5.1M | |
0.0 | 1M | 2.1M | |
33.3M | 2.4M | 3.5M | |
42.4M | 33.6M | 32.8M | |
NON-CURRENT LIABILITIES | |||
16.1M | 136.4M | 134M | |
303K | 789.6M | 774.3M | |
16.4M | 944.6M | 929.8M | |
22.1M | 24M | 26.6M | |
58.8M | 978.2M | 962.6M | |
SHAREHOLDERS' EQUITY | |||
85K | 6K | 5K | |
1.4B | 112.2M | 97.5M | |
-1.1B | -971M | -874.5M | |
-425K | -772K | -501K | |
300.6M | -859.5M | -777.6M | |
300.6M | -859.5M | -777.6M | |
SUMMARY | |||
359.5M | 118.7M | 185.1M | |
235.4M | 0.0 | 0.0 | |
22.1M | 160.4M | 160.6M | |
-22.7M | 109M | 37.8M | |
83,396,100 | 83,396,100 | 83,396,100 |
HTFL - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
10-Q 10-Q 2026 Q1 Q1 | May 14, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 14, 2026 | May 14, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 29, 2026 | June 16, 2026 | 2026 | |
10-K 10-K 2025 FY FY | March 18, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | March 18, 2026 | March 18, 2026 | 2026 | |
8-K 8-K 2026 N/A | January 12, 2026 | January 12, 2026 | 2026 | |
10-Q 10-Q 2025 Q3 Q3 | November 12, 2025 | September 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 12, 2025 | November 12, 2025 | 2025 | |
10-Q 10-Q 2025 Q2 Q2 | September 19, 2025 | June 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | September 10, 2025 | September 10, 2025 | 2025 |
Continue your HTFL research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.